These carefully selected companies are predicted to grow significantly faster than average. Our professional analysts have identified these stocks for their strong innovation focus and potential to deliver exceptional returns.
Professional analysts have specifically highlighted these stocks for their above-average growth potential in the coming 12 months, making them particularly worth watching.
These companies consistently reinvest profits into breakthrough research and development, potentially creating significant value that could translate to higher share prices.
By focusing on companies across diverse sectors with strong growth trajectories, you're positioning yourself to potentially benefit from the next wave of market leaders.
We've selected companies with impressive track records of generating profits while heavily reinvesting in research and development. This strategic reinvestment in innovation could fuel substantial growth in revenue and share value over time.
Growth stocks span diverse sectors including technology, healthcare, and clean energy. These companies typically prioritize expansion and innovation over immediate dividends, making them particularly attractive for investors seeking potential long-term appreciation.
Each company in this collection has been handpicked by professional analysts who predict significant growth potential over the next 12 months. Their strong focus on innovation and successful reinvestment of profits makes them stand out as potentially rewarding investments.
Structured data for the High Growth Stocks basket provided for internal use.
MSFT: $3.85T
GOOGL: $3.03T
AMZN: $2.37T
Here are a few of the assets in this group. Create an account to unlock the full list.
Unlock all stocks by downloading the app for FREE.
Es dauert nur 60 Sekunden.
Analysten erwarten im Durchschnitt, dass die Werte dieser Gruppe im nächsten Jahr um 22.98 % zulegen.
6 von 7 Werten dieser Gruppe werden von professionellen Analysten mit „Kaufen“ bewertet.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
Wenn Sie in diese Werte investieren:
In 12 Monaten könnte der Wert betragen:
+22.98%
Erfahren Sie alles über diesen Aktienkorb. Lesen Sie unseren ausführlichen Artikel zu seinen Risiken und seinem Potenzial.
Vollständige Analyse lesen
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
